TriVirum Company Profile

Background

TriVirum Inc., founded in 2018, is an early-stage medical device company headquartered in Lincoln, California. The company specializes in developing cost-effective, medical-quality sensors that provide clinicians with actionable information to improve patient health outcomes globally while reducing healthcare costs.

Key Strategic Focus

TriVirum leverages advanced semiconductor and signal processing technologies to create innovative medical devices. Their primary focus is on developing wearable sensors for continuous health monitoring, particularly targeting cardiac conditions. The company's solutions aim to offer superior test quality at lower costs, facilitating widespread deployment and addressing the needs of vulnerable populations at risk of serious health events.

Financials and Funding

Since its inception, TriVirum has secured multiple funding rounds:

March 2021: Raised $1.24 million in a seed round.

June 2022: Completed another seed round; specific details undisclosed.

July 2023: Raised $3 million of the $4 million sought in equity funding.

January 2024: Secured $9.1 million in equity funding.

Notable investors include Almond Tree Capital, Par Equity, and Particular Ventures.

Pipeline Development

TriVirum's flagship product is a wearable cardiac ambulatory monitoring device designed for continuous monitoring of patients at risk of developing or who have atrial fibrillation. In the summer of 2023, the device underwent clinical trials at the Clayton Sleep Institute in St. Louis, focusing on adults aged 65 to 90.

Technological Platform and Innovation

TriVirum's innovation lies in its integration of semiconductor and signal processing technologies to develop medical sensors. The company's proprietary technologies include:

Advanced Semiconductor Technology: Utilized to create cost-effective, high-quality sensors.

Signal Processing Algorithms: Designed to provide accurate and actionable health data to clinicians.

Leadership Team

Bill Willis: Director and Consultant. Also serves as Managing Director of Key Harbor Group LLC, a medical technology consulting firm in Seattle.

Yasmin Seyal: Chief Financial Officer. Former CFO at GenCorp Inc. (now Aerojet Rocketdyne Holdings Inc.) and global treasurer at VSP Vision.

Tim Richter: Co-Founder, Chief Commercialization Officer, Vice President of Business Development, and Board Member.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within TriVirum's leadership team.

Competitor Profile

Market Insights and Dynamics

The medical device industry, particularly the wearable health monitoring segment, is experiencing significant growth. The increasing prevalence of chronic diseases and the emphasis on preventive healthcare are driving demand for innovative monitoring solutions.

Competitor Analysis

Key competitors in the wearable cardiac monitoring space include:

iRhythm Technologies: Specializes in wearable ECG monitoring devices.

BioTelemetry (a Philips company): Offers remote cardiac monitoring services.

AliveCor: Develops personal ECG devices integrated with smartphones.

These companies focus on providing accurate, user-friendly, and cost-effective cardiac monitoring solutions, contributing to a competitive landscape that emphasizes innovation and patient-centric designs.

Strategic Collaborations and Partnerships

TriVirum has secured investments from notable venture capital firms, including Almond Tree Capital, Par Equity, and Particular Ventures. These partnerships provide financial support and strategic guidance, enhancing the company's market position and innovation capacity.